American Diabetes Association Announces Tamara Darsow, PhD, As New Vice President, Research Programs
January 19, 2011
The American Diabetes Association announced today that Tamara “Mara” Darsow, PhD, has been named the Association’s Vice President of Research Programs. As a part of the Association’s Scientific & Medical Division leadership team, Darsow will oversee the research grants programs and research committees, while also providing scientific support for the Association’s Research Foundation.
Prior to accepting her position with the Association, Darsow was the Director of External Research Programs and Strategic Relation at Amylin Pharmaceuticals, Inc. In this role she provided oversight of all Amylin external research programs as well as scientific support for Amylin marketing and medical affairs. Previous to her work at Amylin, Darsow was a Damon Runyon Post-Doctoral Fellow at the Salk Institute in La Jolla, California, where she developed and led an independent research program. Darsow has co-authored numerous publications and abstracts, many focusing on type 1 and type 2 diabetes.
“Mara’s experience in clinical and basic research, medical communications, and grants program management make her uniquely qualified for her position,” said David Kendall, MD, Chief Scientific & Medical Affairs Officer. “We look forward to her contributions towards the Association’s research efforts.”
In 2010, the American Diabetes Association made $34.1 million available to support the broad spectrum of diabetes research. This funding supported 338 awards at more than 125 leading research institutions in the United States, averaging more than five published papers per currently funded investigator. Over the years, the Association has invested more than $530 million in diabetes research and provided funding for more than 4,000 research projects.
Darsow holds a PhD in Cell and Molecular Biology from the University of California at San Diego and a BS in Microbiology from Montana State University.
About the American Diabetes Association
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)